Cochlear Share Price and Company Fundamentals
Last traded: Today at 3:43 AM
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered in Sydney, Australia.
Key Metrics
PE ratio
43.92
PB ratio
8.76
Dividend yield
1.61%
Beta
0.51
Market cap
$17.09B
Enterprise value
$17.41B
Company profile
| Industry / Sector | Medical Devices / Healthcare |
|---|---|
| Full time employees | 5500 |
| Website | https://www.cochlear.com |
| Mailing address | 1 University Avenue Macquarie University Sydney NSW 2109 Australia |
| Phone / Fax | 61 2 9428 6555 / 61 2 9428 6353 |
Dividends
More: Cochlear Dividend history, yield and payout ratio
Dividend yield
1.61%
Dividend amount
$4.30
Payout ratio
71.51%
5Y Avg. yield
-%
Cochlear paid $4.30 dividend and the ex-dividend date was 18 Sep 2025.The dividend payout ratio is 71.51%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.COH dividend payout ratio is between 70-90%. The lower dividend payout ratio is preferrable since it provides company margin to grow the dividends in future.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Cochlear.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Diggory William Howitt BE (Hons), MBA | CEO, MD, President & Executive Director | 58 | |
| Dr. Sarah Thom | Chief Financial Officer | ||
| Mr. Jan Janssen MSc Elec Eng | Chief Technology Officer | 60 | |
| Mr. Stuart Sayers | President of Asia Pacific & Latin America | ||
| Ms. Karen O'Driscoll | Chief Information Officer | ||
| Ms. Kristina Devon | VP of Corporate Strategy & Investor Relations | ||
| Mr. Rob McGrory | Group General Counsel & Company Secretary | ||
| Ms. Jennifer Stevenson | VP of Corporate Communications & Brand | ||
| Mr. Dean Phizacklea | Senior Vice President of Global Strategic Marketing | ||
| Ms. Jennifer Hornery | Senior Vice President of Global People & Culture |
Profitability and management effectiveness
Profit margin
16.60%
Operating margin
21.44%
Return on assets
11.73%
Return on equity
20.52%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Cochlear is 17.09B and its enterprise value is 17.41B. The enterprise value to revenue ratio of COH is 7.43. The enterprise value to EBITDA ratio of COH is 30.34.
The COH's stocks Beta value is 0.51 making it 49% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Cochlear (COH)
- Ansell (ANN)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Polynovo (PNV)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Cochlear (ASX:COH) Frequently Asked Questions
1. What is Cochlear's Stock Symbol?
Cochlear trades on ASX under the ticker symbol "COH".
2. What is Cochlear's stock price today?
One share of COH stock can currently be purchased for approximately $261.35.
3. How can I contact Cochlear?
Cochlear's mailing address is 1 University Avenue Macquarie University Sydney NSW 2109 Australia. The company can be reached via phone at 61 2 9428 6555.
4. What is Cochlear's official website?
The official website of Cochlear is https://www.cochlear.com.